glp 1 and liver enzymes glp-1 Multiple target tissue effects of analogues on non-alcoholic fatty disease (NAFLD) non-alcoholic steatohepatitis (NASH) GLP-1_receptor_som_behandling_af_steatotisk_leversygdom GLP-1 improves liver health independent

Following the dose-optimization period, subjects continued on their optimized dose for the duration of the dose-maintenance period

Mansoor et al

Adverse effects on CV outcomes were associated with baseline insulin treatment for participants in the drug treatment groups (RR = 1.52

PMID: 18492290 (This study is OPEN ACCESS if you would like to read it) The scientists in this study tested exendin-4 on two different rodent models of Parkinsons (6-hydroxydopamine and lipopolysaccaride), and they found similar results to the previous study

Before starting GLP-1 therapy, a healthcare provider will review your medical history, current medications, and overall health to ensure the treatment is safe and suitable for you